top of page

XLerateHealth Selects Seven Healthcare Startups for 2020 Accelerator Cohort in Louisville

August 04, 2020 08:00 AM Eastern Daylight Time

​

A nationally recognized healthcare accelerator headquartered in Louisville, today announced the selection of seven healthcare startups including Tampa based company.

​

“IBIS Therapeutics (Tampa, FL) tackles the problem of therapeutic efficacy using a unique AI engine capable of predicting absorption, distribution, metabolism, excretion and toxicity to identify the best drug candidates from a quarter billion small molecules. IBIS’s first to market product will focus on COVID-19 and inflammation which enables a cost-effective drug discovery process to investigate every protein in the SARS-CoV-2 viral proteome for drug candidates in a few months compared to the time required for traditional compound discovery.”

​

Read the full article on Business Wire here.

ibis therapeutics fingerprint logo
Our Molecular Fingerprint™ Platform evaluates all possible interactions between diverse arrays of drug candidates with the largest curated collection of both disease-modifying and toxicity-causing protein targets.

Explore

USF Connect Building

3802 Spectrum Blvd, Suite146

Tampa, FL 33612

©2022 IBIS Therapeutics

bottom of page